POLL>>🪙 | 💰 31 US Stocks Hit New Highs: BAC, MRK, TD, SCHW, BMO,...

💬 Join the discussion: Vote in our poll below and share your take in the comments — every useful comment earns Tiger Coins! 🎁

Thirty-one U.S. stocks with market caps above $10 billion are trading at fresh all-time highs as of August 14, 2026. The top 10 are dominated by banking — spanning U.S. money-center and super-regional lenders, Canadian money-center banks, discount brokerage/wealth management, and global custody banking — alongside one large-cap pharmaceutical name in oncology and cardiopulmonary biopharma. This concentration points to a broad-based bank earnings supercycle (double-digit EPS growth across trading, fee income, and net interest income), a wave of positive operating leverage at the major Canadian banks, and continued pipeline-driven re-rating in large-cap pharma as the market's current momentum drivers.

The top 10 tickers leading this cohort - $Bank of America(BAC)$, $Merck(MRK)$, $Toronto-Dominion Bank(TD)$, $Charles Schwab(SCHW)$, $Bank of Montreal(BMO)$, $Canadian Imperial Bank of Commerce(CM)$, $Bank of Nova Scotia(BNS)$, $Bank of New York Mellon(BNY)$, $PNC Financial Services Group Inc(PNC)$, $U.S. Bancorp(USB)$

• Bank Earnings Supercycle: Q2 2026 was a blowout quarter across the group — $Bank of America(BAC)$, $Charles Schwab(SCHW)$, $PNC Financial Services Group Inc(PNC)$, $U.S. Bancorp(USB)$, and $Bank of New York Mellon(BNY)$ all posted double-digit EPS growth and beat consensus by wide margins. Fee income, trading, and net interest income are all expanding simultaneously, a combination banks haven't enjoyed in years.

• Canadian Banks Riding Positive Operating Leverage: $Toronto-Dominion Bank(TD)$, $Bank of Montreal(BMO)$, $Canadian Imperial Bank of Commerce(CM)$, and $Bank of Nova Scotia(BNS)$ all delivered fiscal Q2 results with record or near-record segment earnings and continued positive operating leverage. Analysts across Scotiabank, TD Securities, RBC, and National Bank Financial have been raising price targets in lockstep through July and August.

• Capital Markets and Trading Boom: $Bank of America(BAC)$'s Global Markets net income jumped 70% YoY, $Charles Schwab(SCHW)$ logged record daily trading volume of 11.9 million trades, and $U.S. Bancorp(USB)$'s newly acquired BTIG contributed $98 million in its first month alone. Wall Street's dealmaking and trading engines are firing together.

• Healthcare M&A and Pipeline Derisking: $Merck(MRK)$'s $6.8 billion Terns Pharmaceuticals acquisition weighed on near-term EPS but underscores a broader push to diversify beyond KEYTRUDA ahead of its 2028 patent cliff, with management citing faster-than-expected clinical derisking across the pipeline.

1. $Bank of America(BAC)$

• Core Business:
  Consumer and commercial banking, wealth management, investment banking, and trading, organized across four segments: Consumer Banking, Global Wealth & Investment Management, Global Banking, and Global Markets.

• Latest Developments:
  On July 14, 2026, BofA reported Q2 2026 results showing Global Markets net income up 70% YoY to $2.7 billion, with investment banking fees up 50% to over $2.1 billion, the bank's strongest IB quarter in years.

• Latest Earnings Highlights:
  Q2 2026 revenue rose 15% YoY to $31.6 billion, net income climbed 27% to $9.1 billion, and diluted EPS grew 34% to $1.21 versus a $1.13 estimate. Sales and trading revenue hit $7.2 billion (+33%), NII rose 9% to $16.2 billion, and the bank returned $8 billion to shareholders.

• Price Target Outlook:
  UBS analyst raised the price target from $68 to $70 on August 3, 2026, maintaining Buy. Wells Fargo raised its target from $67 to $69 on July 15, 2026, keeping Overweight.

2. $Merck(MRK)$

• Core Business:
  Pharmaceuticals spanning oncology (KEYTRUDA), vaccines, cardiopulmonary therapies, and animal health.

• Latest Developments:
  On August 4, 2026, Merck reported Q2 results alongside a $2.31-per-share charge tied to its $6.8 billion acquisition of Terns Pharmaceuticals. The FDA also approved LIPFENDRA, the first oral PCSK9 inhibitor, during the quarter.

• Latest Earnings Highlights:
  Q2 2026 revenue rose 5% YoY to $16.6 billion; KEYTRUDA family sales grew 4% to $8.4 billion (including $463 million from subcutaneous KEYTRUDA QLEX); WINREVAIR sales jumped 75% to $588 million. Non-GAAP EPS was a loss of $0.13 due to the acquisition charge; FY2026 revenue guidance was raised to $66.3–$67.3 billion.

• Price Target Outlook:
  Argus raised its price target from $130 to $145 on August 10, 2026. Barclays raised its target from $140 to $150 on July 29, 2026, maintaining Buy.

3. $Toronto-Dominion Bank(TD)$

• Core Business:
  Canadian personal and commercial banking, U.S. banking, wealth management and insurance, and wholesale banking.

• Latest Developments:
  TD's fiscal Q2 2026 results (reported in late May 2026) featured record quarterly earnings in Canadian Personal and Commercial Banking and all-time-high earnings in Wealth Management and Insurance and Wholesale Banking, alongside a fourth consecutive quarter of positive adjusted operating leverage.

• Latest Earnings Highlights:
  Fiscal Q2 2026 adjusted EPS came in at C$2.38, up from C$1.97 a year earlier, on adjusted revenue of C$16.04 billion versus C$15.14 billion in the prior-year quarter.

• Price Target Outlook:
  Scotiabank raised its price target from C$165 to C$169 on June 16, 2026, maintaining Outperform. National Bank Financial raised its target from C$162 to C$190 on August 13, 2026, keeping Outperform.

4. $Charles Schwab(SCHW)$

• Core Business:
  Brokerage, wealth management, banking, and trading services for retail and institutional clients.

• Latest Developments:
  On July 21, 2026, Schwab reported record Q2 2026 results with $13.08 trillion in total client assets and 11.9 million daily average trades, while bank lending balances reached $67 billion, up 33% YoY.

• Latest Earnings Highlights:
  Q2 2026 revenue rose 21% YoY to a record $7.1 billion, and adjusted EPS grew 42% to $1.62, beating the $1.51 estimate. Management raised full-year revenue growth guidance to 17.5%–18.5%.

• Price Target Outlook:
  Argus raised its price target from $108 to $114 following the Q2 beat, maintaining Buy. Morgan Stanley set a $133 price target, citing Schwab's diversifying revenue base.

5. $Bank of Montreal(BMO)$

• Core Business:
  Canadian and U.S. personal and commercial banking, wealth management, and capital markets.

• Latest Developments:
  BMO reported fiscal Q2 2026 results on May 27, 2026, with earnings coming in well ahead of Street expectations, prompting a wave of price-target increases across Canadian and U.S. brokerages through the summer.

• Latest Earnings Highlights:
  Fiscal Q2 2026 EPS was C$2.614, beating the consensus estimate of C$2.458 by C$0.156.

• Price Target Outlook:
  Desjardins raised its price target from C$230 to C$260 on August 5, 2026, with a Hold rating. Canaccord Genuity raised its target from C$242 to C$265 on July 7, 2026, maintaining Buy.

6. $Canadian Imperial Bank of Commerce(CM)$

• Core Business:
  Canadian personal and business banking, Canadian commercial banking and wealth management, U.S. commercial banking and wealth management, and capital markets.

• Latest Developments:
  CIBC's fiscal Q2 2026 report showed sharply higher earnings, with management citing broad-based revenue growth, positive operating leverage, and a strong capital position.

• Latest Earnings Highlights:
  Quarterly EPS rose sharply from the prior-year period, with the bank's 2026 EPS consensus subsequently revised up from roughly C$9.42 to C$10.57 following the results.

• Price Target Outlook:
  TD Securities raised its price target from C$163 to C$175 on August 13, 2026, maintaining Buy. RBC Capital raised its target from C$147 to C$167, keeping Outperform.

7. $Bank of Nova Scotia(BNS)$

• Core Business:
  Canadian banking, international banking (notably Latin America), global wealth management, and global banking and markets.

• Latest Developments:
  Scotiabank's fiscal Q2 2026 results, reported May 27, 2026, showed continued improvement in profitability metrics as the bank executes its North American-focused strategy.

• Latest Earnings Highlights:
  Fiscal Q2 2026 EPS was C$2.02 on revenue of C$9.85 billion, with a net margin of 15.64% and return on equity of 11.06%.

• Price Target Outlook:
  TD Securities raised its price target from C$113 to C$124 on August 13, 2026, with a Hold rating. National Bank Financial raised its target from C$106 to C$128 the same week.

8. $Bank of New York Mellon(BNY)$

• Core Business:
  Global custody, securities services, market and wealth services, and investment and wealth management.

• Latest Developments:
  On July 15, 2026, BNY reported record Q2 2026 results and raised its 2026 revenue growth guidance to 10%–11%, while also increasing its quarterly dividend by 19% to $0.63 per share.

• Latest Earnings Highlights:
  Q2 2026 revenue rose 13% YoY to a record $5.7 billion, EPS grew 27% to $2.45, pretax margin expanded to 40%, and return on tangible common equity reached 31%.

• Price Target Outlook:
  Truist raised its price target to $178 and maintained a Buy rating following the results.

9. $PNC Financial Services Group Inc(PNC)$

• Core Business:
  Regional and commercial banking, asset management, and residential/commercial mortgage services, expanded via the FirstBank acquisition.

• Latest Developments:
  PNC reported Q2 2026 results on July 14, 2026, with record revenue, net interest income, and fee income, and raised its quarterly dividend 18% to $2.00 per share.

• Latest Earnings Highlights:
  Q2 2026 net income was $2.1 billion ($4.81 diluted EPS); adjusted EPS of $4.85 beat estimates by $0.30 on revenue of $6.88 billion, topping the $6.5 billion consensus. Fee income rose 20% YoY.

• Price Target Outlook:
  BofA analyst Ebrahim Poonawala raised the price target from $289 to $291, maintaining Buy. Barclays analyst Jason Goldberg raised his target from $277 to $284, keeping Overweight.

10. $U.S. Bancorp(USB)$

• Core Business:
  Consumer and business banking, payment services, and wealth/corporate/commercial/institutional banking, recently expanded through the BTIG acquisition.

• Latest Developments:
  On July 16, 2026, USB reported record Q2 2026 net revenue, with the newly acquired BTIG capital-markets business contributing $98 million in its first month, and raised full-year 2026 revenue growth guidance to 7%–9% from 4%–6%.

• Latest Earnings Highlights:
  Q2 2026 EPS rose 22% YoY to $1.35, beating the $1.27–$1.28 consensus, on record net revenue of $7.7 billion (+10.1% YoY). Fee income rose 13.2%, and net interest income grew 7.5% to $4.4 billion.

• Price Target Outlook:
  Citi raised its price target from $70 to $72, maintaining Buy, citing improved earnings visibility.

🐯 Your Turn: Which New-High Trade Still Has Room to Run?

📊 Quick Poll: With 31 U.S. stocks hitting fresh all-time highs, which theme do you think has the most upside left from here?

A) U.S. Banks & Brokers — BAC, SCHW, BNY, PNC, USB
B) Canadian Banks — TD, BMO, CM, BNS
C) Pharma — MRK
D) None — I'd wait for a pullback before chasing new highs

Vote below, then tell us:

• Which ONE stock from the top 10 would you be most willing to buy at today's level — and why?

• Do you think the bank rally is still being driven by improving fundamentals, or has valuation started to run ahead of earnings?

• Bonus: Which ticker do you think will be the first to set another fresh all-time high over the next 30 days?

🎁 Every useful and thoughtful comment will receive Tiger Coins!

Let's see whether Tiger traders are still chasing the breakout — or waiting for the dip. 🐯📈